Artilysin®: Promising Approach Against Acinetobacter baumannii Infected Wounds streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Severe wound infections increasingly prove to be a serious medical challenge. Complications particularly arise from the high number of infections caused by resistant or multi-resistant pathogens. This
Lysando AG market leader in the field of antimicrobial proteins has signed a general development agreement with Amicogen Inc., a publicly traded biotechnology company and CDMO headquartered in South
TRIESENBERG, Liechtenstein (BUSINESS WIRE) #Artilysin Lysando AG – market leader in the field of antimicrobial proteins – is pleased to announce that Fabian Geldmacher, M.D., has joined the team as Director Strategy & Business Development in June. Dr. Geldmacher will be responsible for shaping Lysando's strategy.
Lysando AG market leader in the field of antimicrobial proteins is pleased to announce that Wilhelm von Haller has joined the team as Chief Financial Officer this March. Baron von Haller is an expert